As Cancer Survival Reaches a New High, More Cancer Patients Are Living Longer Than Ever
A new report from the American Cancer Society offers a clear look at how the country is faring in the fight against cancer, and the data show that ongoing research is driving real progress for patients. The 2026 Cancer Statistics report finds that more Americans are surviving cancer than ever before, even as more than 2.1 million new cases are expected this year.
What Does the 2026 Cancer Statistics Report Show About Cancer Survival?
Jasmin Jerez-Marte, MD
The report shows that cancer survival rates continue to improve, with more patients living longer after diagnosis than at any point in history.
One of the biggest takeaways is a milestone that many experts have been working toward for decades. The five-year relative survival rate for all cancers combined has reached 70%.
“That means 7 out of 10 people diagnosed with cancer today are alive five years later,” said Jasmin Jerez-Marte, MD, chief of the Cancer Survivorship Program at Moffitt Cancer Center. “It is a meaningful improvement over the early 1990s and a dramatic shift from the 1970s.”
Why Are Cancer Survival Rates Improving?
Advances in cancer treatment, research, and personalized care are helping more patients achieve better outcomes.
The report shows that survival is improving even for cancers once considered among the most difficult to treat. Multiple myeloma, liver cancer, melanoma, and lung cancer have all seen significant gains.
These improvements are tied to advances in treatment, including:
- Targeted therapies
- immunotherapy
- CAR T-cell therapy
- More personalized chemotherapy guided by tumor biomarkers.
Moffitt researchers have played a key role in advancing several of these approaches, including early clinical trials that helped bring CAR T therapies to patients with blood cancers.
“Treatments are becoming more precise, which is allowing more people to live longer and better after a cancer diagnosis,” Jerez-Marte said. “We see the impact every day in our clinics as patients benefit from therapies that did not exist a decade ago.”
What Is Cancer Survivorship Care and Why Is It Important?
Cancer survivorship care supports patients throughout and beyond treatment, helping them manage their health and quality of life.
As survival improves, the number of long-term survivors continues to grow. Survivorship clinics now care for millions of people nationwide, and the report emphasizes that survivorship care should begin early in the cancer journey rather than after treatment ends.
Moffitt’s survivorship program has expanded in recent years to support this growing population with coordinated care that addresses physical and psychosocial needs.
“Survivorship is not just for people who are considered cured,” Jerez-Marte said. “It is essential for every patient. We focus on optimizing health, supporting treatment tolerance and managing both cancer-related and unrelated conditions to help people live well for years to come.”
Why Continued Investment in Cancer Research and Access to Care Matters
Ongoing investment in research and patient access to care remains essential to sustaining progress in cancer survival.
The report also highlights the importance of continued investment in cancer research and in access to care. Progress in survival has been steady for decades, but experts warn that funding cuts or reduced access to treatment could slow or reverse these gains.
Institutions such as Moffitt rely on sustained research support to develop new therapies and improve outcomes.
“We have made tremendous progress, but we cannot take it for granted,” Jerez-Marte said. “Sustained investment in cancer care and research is critical to keep moving forward.”
What These Findings Mean for Cancer Patients
The latest survival data reinforce the impact of decades of scientific progress and underscore the importance of continued innovation in cancer care.
As more effective therapies become available and survivorship programs continue to expand, patients are living longer and receiving support that addresses both treatment outcomes and long-term well-being. The findings from the 2026 Cancer Statistics report demonstrate how research, clinical trials and coordinated survivorship care are contributing to improved outcomes for people affected by cancer today and in the future.